Concepedia

Mingjun Rao

MR

Statistics

Publications

4

Citations

148

H-Index

4

Active since

2018

Affiliations

Zhejiang University(Current)

Hangzhou First People's Hospital

Zhejiang Chinese Medical University

Mingjun Rao is an author at Zhejiang University specializing in oncology, medicine, and cancer cell proliferation inhibition.

Publications per year

2018–2020

4

Publications

4

DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild‐type NSCLC cells to AZD9291

Yang-ling Li, Ke Ding, Xiu Hu et al. · Journal of Cellular and Molecular Medicine · 2019 · 53 citations · Full text

, , +17

<p>Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment</p>

Lin‐wen Wu, Jiankang Zhang, Mingjun Rao et al. · OncoTargets and Therapy · 2019 · 42 citations · Full text

, , +17

Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia

Yang-ling Li, Ning-yu Zhang, Xiu Hu et al. · Biochemical and Biophysical Research Communications · 2018 · 27 citations · Full text

, , +14

DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors

Yangling Li, Dongmei Zhou, Shuang Xu et al. · Cancer Biology and Medicine · 2020 · 26 citations · Full text

, , +15

1–4 of 4